PP
ARKG icon

Prudential plc’s ARK Genomic Revolution ETF ARKG Stock Holding History

Prudential plc’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.34M Sell
31,770
-10,300
-24% -$328K 0.01% 453
2026
Q1 		$1.11M Sell
42,070
-5,700
-12% -$167K 0.01% 461
2025
Q4 		$1.38M Buy
47,770
+12,500
+35% +$375K 0.01% 438
2025
Q3 		$979K Sell
35,270
-101,200
-74% -$2.56M 0.01% 482
2025
Q2 		$3.32M Sell
136,470
-45,200
-25% -$990K 0.02% 330
2025
Q1 		$3.77M Buy
181,670
+21,300
+13% +$535K 0.02% 313
2024
Q4 		$3.78M Buy
160,370
+15,200
+10% +$374K 0.02% 289
2024
Q3 		$3.72M Buy
145,170
+5,000
+4% +$127K 0.02% 301
2024
Q2 		$3.33M Buy
140,170
+18,300
+15% +$462K 0.02% 321
2024
Q1 		$3.5M Sell
121,870
-3,900
-3% -$117K 0.03% 314
2023
Q4 		$4.31M Buy
125,770
+8,400
+7% +$228K 0.04% 269
2023
Q3 		$3.27M Sell
117,370
-6,200
-5% -$203K 0.04% 281
2023
Q2 		$4.17M Sell
123,570
-8,600
-7% -$270K 0.05% 243
2023
Q1 		$3.79M Hold
132,170
– – 0.04% 246
2022
Q4 		$3.73M Sell
132,170
-5,000
-4% -$159K 0.05% 247
2022
Q3 		$4.51M Sell
137,170
-8,700
-6% -$319K 0.07% 179
2022
Q2 		$4.69M Buy
145,870
+8,000
+6% +$280K 0.09% 163
2022
Q1 		$6.45M Buy
137,870
+6,570
+5% +$313K 0.09% 124
2021
Q4 		$8.17M Buy
131,300
+10,700
+9% +$740K 0.11% 84
2021
Q3 		$8.91M Buy
120,600
+300
+0.2% +$25.2K 0.12% 74
2021
Q2 		$11.1M Buy
120,300
+22,100
+23% +$1.88M 0.1% 133
2021
Q1 		$8.71M Buy
+98,200
New +$9.74M 0.06% 253
2020
Q4 		– Sell
-44,950
Closed -$2.86M – 608
2020
Q3 		$2.86M Buy
44,950
+16,400
+57% +$961K 0.01% 330
2020
Q2 		$1.49M Buy
+28,550
New +$1.22M 0.01% 365

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Prudential plc's ARKG Position: Q2 2026 in Review

Prudential plc reduced its ARK Genomic Revolution ETF (ARKG) stake by 24% in Q2 2026, selling an estimated $328K and leaving 31,770 shares worth $1.34M. The position accounts for 0.01% of the portfolio, ranked #453.

Prudential plc first reported a position in ARKG in Q2 2020 and has held it in 24 quarters since. The position peaked at $11.1M in Q2 2021. 272 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Prudential plc held 31,770 shares of ARK Genomic Revolution ETF worth $1.34M as of Q2 2026.
  • Prudential plc sold 10,300 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $328K.
  • ARK Genomic Revolution ETF made up 0.01% of Prudential plc's portfolio in Q2 2026, its #453 holding.
  • Prudential plc first reported a position in ARK Genomic Revolution ETF in Q2 2020 and has held it in 24 quarters since.
  • Prudential plc's ARK Genomic Revolution ETF position peaked at $11.1M in Q2 2021.
  • 272 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Prudential plc's 13F filing for Q2 2026, filed 14 Aug 2026.